GHK-Cu before & after.

GHK-Cu results and timing

GHK-Cu results include measured changes in wrinkles and eyebrows, plus individual accounts of smoother skin and a fuller under-eye appearance. They come from different products and routes. A topical result cannot predict the response to a pen, vial or nasal spray.

Fine lines after eight weeks

Mean wrinkle volume changed by −24.1% with GHK-Cu serum and −15.0% with vehicle after eight weeks in the 20-person vehicle-comparison cohort. [1]

The published 55.8% is a comparative improvement, not a change from baseline.

The difference between the displayed average changes is 9.1 percentage points. That calculation makes the result easier to interpret: both sides changed, with a greater reduction on the active-formula side. A photograph of only the active side would miss the improvement seen with the comparison base.

Wrinkle volume is a three-dimensional surface measurement. It is not a percentage of all facial wrinkles removed, a collagen-biopsy result or a number of years taken off someone's appearance. The formulation and the endpoint both matter when translating the result into a cosmetic claim.

Eyebrow density after twelve weeks

Eyebrow hair count increased modestly with topical GHK-Cu. Opposite eyebrows received active serum and vehicle; counts came from a defined 1 cm² area. [2]

The week-12 between-side difference was statistically significant. Small conference-proceedings study.

The decimal figures are averages across participants. No individual grew a fraction of a hair. An average increase of 1.61 hairs in the measured patch is also different from doubling eyebrow density. The finding supports further study of fuller brows; it does not supply a scalp-baldness success rate.

It would be a separate claim to say that injections or nasal GHK-Cu reproduce this result. The study tested a topical eyebrow formula, not a whole-body hair-growth treatment.

Skin redness and texture after fifty-six days

A cream combining 0.2% GHK-Cu with 5% ferment extract improved several skin measurements. Thirty participants completed the 56-day evaluation; everyone received the same cream. There was no vehicle-only human group. [4]

Hydration and redness also improved, but the result belongs to the complete cream. Dermatologist-rated nasolabial lines did not improve. [4]

A pore score is an appearance rating, not a direct measurement of each pore's diameter. Improvement on one facial feature does not mean every feature improved. The unchanged nasolabial score is useful context for anyone expecting a cream to change deeper facial folds.

Under-eye appearance after six weeks

Under-eye hollowness improved partly, rather than disappearing. A 36-year-old contributor described six weeks at 2 mg daily. Substantial weight loss preceded the experiment, and further weight loss continued during the period. The author also described initial injection burning. [3]

A later reply described some return of the under-eye problem after stopping. Earlier creams and microneedling, changing weight and nonstandard photographs limit what can be attributed to GHK-Cu. This is an appearance account, not evidence that lost facial fat was restored. [3]

The amount describes that person's experiment. The dosage and calculator page keeps reported schedules separate from concentration and syringe-scale arithmetic.

Skin and hair appearance after eleven weeks

A 44-year-old contributor described clearer-looking skin and fuller, shinier hair at eleven weeks. The schedule rose from 1.5 to 2 to 2.5 mg, five days weekly. Vitamin C and other skincare continued. Initial stinging later eased. Hair density was not measured. [5]

Shine, softness, reduced breakage and a new hair count are not interchangeable outcomes. Only the last one directly answers a density question. A positive personal experience can be useful without being expanded into a claim that everyone should expect the same change.

No visible skin change after three months

Three months of daily use did not produce an obvious skin improvement for one contributor. GHK-Cu was used alone or within KLOW at different times. The account mentioned a separate back-pain improvement with KLOW, which cannot identify a GHK-Cu skin effect. [6]

Topical experiences also include nonresponse. In a separate skincare discussion, a contributor described consistent copper-peptide application for three months without noticeable differences. [7]

These observations do not cancel the positive trials, just as positive photographs do not erase nonresponse. They answer a practical question: completing several weeks or months does not guarantee that the mirror will show a change. Increasing the amount because a result is absent is not an evidence-based conclusion from either account.

Acne scars after sixteen weeks

Scar scores improved with dermaroller alone and with added copper peptide. In the 40-person comparison, mean quantitative scores changed from 20.7 to 16.2 with dermaroller and from 22.7 to 16.7 with the combination. The groups started at different scores; later between-group differences were not significant. [8]

The larger numerical drop in the combination group cannot be read as proof that the serum was better. Starting severity differed, and participants were not randomly allocated. Comparing each group's starting point with its own ending point answers a different question from whether adding copper peptide caused an extra benefit.

This is also a procedure result. It does not establish that GHK-Cu alone smooths an old acne scar, or that injecting elsewhere on the body achieves the same skin exposure.

Laser recovery at twelve weeks

Objective wrinkle and redness outcomes were similar with and without GHK-Cu after CO2 laser resurfacing. Both groups improved following the procedure. The GHK-Cu group rated its overall skin-quality improvement more highly on a questionnaire. [9]

Those are compatible findings. A patient can prefer how the skin looks or feels while a standardized measure does not detect a treatment advantage. Neither endpoint should be substituted for the other. Satisfaction is not a wrinkle-depth measurement, and an instrument result does not describe every aspect of a person's experience.

Wound-area closure in a diabetic-foot trial

Median plantar-ulcer area closure was 98.5% with the GHK-Cu gel and 60.8% with vehicle. Both groups received structured wound care, including debridement and pressure relief. [10]

98.5% is not the percentage of patients cured. It describes the median change in wound area. For illustration only, a 100-unit wound area reduced by 98.5% would leave 1.5 units; this arithmetic does not recreate an individual patient's wound.

A separate venous-ulcer trial found no advantage of a copper-peptide cream over its vehicle. Different wound causes and formulations produced different results. [11]

These studies cannot supply a healing deadline for a fresh cut, surgical incision or research-product injection. The wound product and the background care are part of the intervention.

Results after stopping GHK-Cu

A permanent result has not been established across these uses. The six-week under-eye account included later regression. The controlled cosmetic studies mainly measured changes during treatment, rather than proving that those changes persisted indefinitely afterward. [3]

A change in hydration, a healing wound and an altered hair count may behave differently after treatment ends. One cannot supply a maintenance schedule for the others. A claim such as “the result lasts six months” needs follow-up for that same outcome and formulation.

The same applies to stopping and restarting. A return of symptoms after stopping can be part of an individual account, but it does not establish an ideal break length or a requirement for lifelong use. The cycle discussion explains the actual schedules that can be sourced.

Vial, pen and nasal-spray results

No credible head-to-head result ranks the supplied vial, pen and nasal spray for skin improvement. The three formats differ in total content, delivery and measurement. Those differences do not establish a fastest option.

A pen is a device format, while a clinical trial tests a defined intervention. Its convenience cannot be converted into a larger wrinkle effect. Likewise, a nasal product cannot borrow the twelve-week eyebrow result simply because it contains the same named peptide.

Use the GHK-Cu product comparison for actual format details and the redacted COA. For the biological findings behind the outcomes, see GHK-Cu benefits. The main peptide guide connects the complete set.